Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
1967-12-16
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0567-655X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
264
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1931-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4293113-Carcinoma, Hepatocellular,
pubmed-meshheading:4293113-Fetus,
pubmed-meshheading:4293113-Fructose-Bisphosphate Aldolase,
pubmed-meshheading:4293113-Humans,
pubmed-meshheading:4293113-Immune Sera,
pubmed-meshheading:4293113-Liver,
pubmed-meshheading:4293113-Liver Neoplasms,
pubmed-meshheading:4293113-Muscles
|
pubmed:year |
1967
|
pubmed:articleTitle |
[Action of muscle-aldolase antiserum on aldolase of human hepatoma and of human fetal liver].
|
pubmed:publicationType |
Journal Article
|